JFG
EVLO

Jefferies Financial Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Jefferies Financial Group’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,750
Closed -$13.6K – 2107
2023
Q1 		$13.6K Buy
+3,750
New +$57.9K ﹤0.01% 1547

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jefferies Financial Group's EVLO Position: Q2 2023 in Review

Jefferies Financial Group sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2023, closing a stake of 3,750 shares — an estimated $13.6K sold.

Jefferies Financial Group first reported a position in EVLO in Q1 2023 and held it in 1 quarter. The position peaked at $13.6K in Q1 2023. 25 funds tracked by Wall St. Rank hold EVLO as of Q2 2023.

  • Jefferies Financial Group reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 3,750 Evelo Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $13.6K.
  • Jefferies Financial Group first reported a position in Evelo Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Jefferies Financial Group's Evelo Biosciences, Inc. Common Stock position peaked at $13.6K in Q1 2023.
  • 25 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2023.

Based on Jefferies Financial Group's 13F filing for Q2 2023, filed 14 Aug 2023.